nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—CACNA1D—cochlea—head and neck cancer	0.0474	0.138	CbGeAlD
Nimodipine—CACNA1D—internal ear—head and neck cancer	0.045	0.131	CbGeAlD
Nimodipine—CACNA1D—ear—head and neck cancer	0.0303	0.0883	CbGeAlD
Nimodipine—Gastrointestinal symptom NOS—Hydroxyurea—head and neck cancer	0.0189	0.0518	CcSEcCtD
Nimodipine—Platelet count decreased—Hydroxyurea—head and neck cancer	0.0187	0.0513	CcSEcCtD
Nimodipine—Ileus—Vinblastine—head and neck cancer	0.0172	0.0472	CcSEcCtD
Nimodipine—Disseminated intravascular coagulation—Docetaxel—head and neck cancer	0.0162	0.0443	CcSEcCtD
Nimodipine—CACNA1F—head—head and neck cancer	0.0153	0.0446	CbGeAlD
Nimodipine—Gastrointestinal symptom NOS—Fluorouracil—head and neck cancer	0.0136	0.0373	CcSEcCtD
Nimodipine—CACNB4—thyroid gland—head and neck cancer	0.0113	0.033	CbGeAlD
Nimodipine—AHR—parotid gland—head and neck cancer	0.011	0.0321	CbGeAlD
Nimodipine—CACNB3—trachea—head and neck cancer	0.011	0.032	CbGeAlD
Nimodipine—AHR—saliva-secreting gland—head and neck cancer	0.0105	0.0307	CbGeAlD
Nimodipine—Phlebitis—Vinblastine—head and neck cancer	0.0103	0.0282	CcSEcCtD
Nimodipine—CACNB4—head—head and neck cancer	0.0101	0.0293	CbGeAlD
Nimodipine—CACNA1S—thyroid gland—head and neck cancer	0.00971	0.0283	CbGeAlD
Nimodipine—Deep vein thrombosis—Docetaxel—head and neck cancer	0.0095	0.026	CcSEcCtD
Nimodipine—CACNB1—thyroid gland—head and neck cancer	0.00906	0.0264	CbGeAlD
Nimodipine—CACNB3—thyroid gland—head and neck cancer	0.00869	0.0253	CbGeAlD
Nimodipine—Ileus—Docetaxel—head and neck cancer	0.00816	0.0224	CcSEcCtD
Nimodipine—AHR—trachea—head and neck cancer	0.00814	0.0237	CbGeAlD
Nimodipine—CACNB1—head—head and neck cancer	0.00804	0.0234	CbGeAlD
Nimodipine—CACNB3—head—head and neck cancer	0.00771	0.0224	CbGeAlD
Nimodipine—NR3C2—parotid gland—head and neck cancer	0.00733	0.0214	CbGeAlD
Nimodipine—CACNA1C—connective tissue—head and neck cancer	0.00709	0.0207	CbGeAlD
Nimodipine—NR3C2—saliva-secreting gland—head and neck cancer	0.00702	0.0205	CbGeAlD
Nimodipine—Depression—Vinblastine—head and neck cancer	0.0068	0.0186	CcSEcCtD
Nimodipine—NR3C2—connective tissue—head and neck cancer	0.00645	0.0188	CbGeAlD
Nimodipine—AHR—thyroid gland—head and neck cancer	0.00644	0.0187	CbGeAlD
Nimodipine—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00588	0.0161	CcSEcCtD
Nimodipine—CACNB2—thyroid gland—head and neck cancer	0.00584	0.017	CbGeAlD
Nimodipine—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00581	0.0159	CcSEcCtD
Nimodipine—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00578	0.0158	CcSEcCtD
Nimodipine—CACNB1—lymph node—head and neck cancer	0.00563	0.0164	CbGeAlD
Nimodipine—Fluid retention—Docetaxel—head and neck cancer	0.00548	0.015	CcSEcCtD
Nimodipine—NR3C2—trachea—head and neck cancer	0.00542	0.0158	CbGeAlD
Nimodipine—CACNB3—lymph node—head and neck cancer	0.0054	0.0157	CbGeAlD
Nimodipine—CACNB2—head—head and neck cancer	0.00518	0.0151	CbGeAlD
Nimodipine—Lightheadedness—Docetaxel—head and neck cancer	0.00517	0.0142	CcSEcCtD
Nimodipine—CACNA1D—thyroid gland—head and neck cancer	0.0051	0.0149	CbGeAlD
Nimodipine—Angiopathy—Hydroxyurea—head and neck cancer	0.00507	0.0139	CcSEcCtD
Nimodipine—Anaemia—Vinblastine—head and neck cancer	0.00493	0.0135	CcSEcCtD
Nimodipine—Phlebitis—Docetaxel—head and neck cancer	0.00487	0.0133	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00482	0.0132	CcSEcCtD
Nimodipine—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00462	0.0127	CcSEcCtD
Nimodipine—Hypertension—Vinblastine—head and neck cancer	0.0046	0.0126	CcSEcCtD
Nimodipine—CACNA1D—head—head and neck cancer	0.00453	0.0132	CbGeAlD
Nimodipine—Anaemia—Hydroxyurea—head and neck cancer	0.00449	0.0123	CcSEcCtD
Nimodipine—NR3C2—thyroid gland—head and neck cancer	0.00429	0.0125	CbGeAlD
Nimodipine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00426	0.0117	CcSEcCtD
Nimodipine—Hyponatraemia—Docetaxel—head and neck cancer	0.00421	0.0115	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00419	0.0115	CcSEcCtD
Nimodipine—CACNA1C—head—head and neck cancer	0.00418	0.0122	CbGeAlD
Nimodipine—AHR—lymph node—head and neck cancer	0.004	0.0116	CbGeAlD
Nimodipine—Oedema—Hydroxyurea—head and neck cancer	0.00397	0.0109	CcSEcCtD
Nimodipine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00389	0.0107	CcSEcCtD
Nimodipine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00388	0.0106	CcSEcCtD
Nimodipine—Liver function test abnormal—Docetaxel—head and neck cancer	0.00387	0.0106	CcSEcCtD
Nimodipine—NR3C2—head—head and neck cancer	0.0038	0.0111	CbGeAlD
Nimodipine—Cramp muscle—Docetaxel—head and neck cancer	0.00378	0.0104	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.0037	0.0101	CcSEcCtD
Nimodipine—CACNB2—lymph node—head and neck cancer	0.00363	0.0106	CbGeAlD
Nimodipine—Dyspnoea—Hydroxyurea—head and neck cancer	0.00354	0.0097	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00343	0.00939	CcSEcCtD
Nimodipine—Amlodipine—CYP1A1—head and neck cancer	0.00336	0.528	CrCbGaD
Nimodipine—Anaemia—Fluorouracil—head and neck cancer	0.00323	0.00887	CcSEcCtD
Nimodipine—Hypersensitivity—Vinblastine—head and neck cancer	0.00321	0.00879	CcSEcCtD
Nimodipine—CACNA1D—lymph node—head and neck cancer	0.00317	0.00923	CbGeAlD
Nimodipine—Jaundice—Docetaxel—head and neck cancer	0.00315	0.00864	CcSEcCtD
Nimodipine—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00306	0.00838	CcSEcCtD
Nimodipine—Nifedipine—CYP1A1—head and neck cancer	0.003	0.472	CrCbGaD
Nimodipine—Myalgia—Fluorouracil—head and neck cancer	0.00298	0.00817	CcSEcCtD
Nimodipine—Diarrhoea—Vinblastine—head and neck cancer	0.00298	0.00816	CcSEcCtD
Nimodipine—CACNA1C—lymph node—head and neck cancer	0.00293	0.00852	CbGeAlD
Nimodipine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00292	0.00801	CcSEcCtD
Nimodipine—Hepatitis—Docetaxel—head and neck cancer	0.0029	0.00795	CcSEcCtD
Nimodipine—Dizziness—Vinblastine—head and neck cancer	0.00288	0.00789	CcSEcCtD
Nimodipine—Oedema—Fluorouracil—head and neck cancer	0.00286	0.00783	CcSEcCtD
Nimodipine—Nervous system disorder—Fluorouracil—head and neck cancer	0.0028	0.00768	CcSEcCtD
Nimodipine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.0028	0.00767	CcSEcCtD
Nimodipine—Tachycardia—Fluorouracil—head and neck cancer	0.00279	0.00764	CcSEcCtD
Nimodipine—Vomiting—Vinblastine—head and neck cancer	0.00277	0.00758	CcSEcCtD
Nimodipine—Headache—Vinblastine—head and neck cancer	0.00273	0.00747	CcSEcCtD
Nimodipine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00271	0.00744	CcSEcCtD
Nimodipine—Flushing—Docetaxel—head and neck cancer	0.00269	0.00738	CcSEcCtD
Nimodipine—Cardiac disorder—Docetaxel—head and neck cancer	0.00269	0.00738	CcSEcCtD
Nimodipine—Hypotension—Fluorouracil—head and neck cancer	0.00267	0.00732	CcSEcCtD
Nimodipine—NR3C2—lymph node—head and neck cancer	0.00266	0.00776	CbGeAlD
Nimodipine—Angiopathy—Docetaxel—head and neck cancer	0.00263	0.00722	CcSEcCtD
Nimodipine—Dizziness—Hydroxyurea—head and neck cancer	0.00262	0.00719	CcSEcCtD
Nimodipine—Immune system disorder—Docetaxel—head and neck cancer	0.00262	0.00718	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.0026	0.00713	CcSEcCtD
Nimodipine—Nausea—Vinblastine—head and neck cancer	0.00258	0.00708	CcSEcCtD
Nimodipine—Dyspnoea—Fluorouracil—head and neck cancer	0.00255	0.00698	CcSEcCtD
Nimodipine—Vomiting—Hydroxyurea—head and neck cancer	0.00252	0.00692	CcSEcCtD
Nimodipine—Rash—Hydroxyurea—head and neck cancer	0.0025	0.00686	CcSEcCtD
Nimodipine—Dermatitis—Hydroxyurea—head and neck cancer	0.0025	0.00685	CcSEcCtD
Nimodipine—Headache—Hydroxyurea—head and neck cancer	0.00249	0.00681	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00247	0.00676	CcSEcCtD
Nimodipine—Muscle spasms—Docetaxel—head and neck cancer	0.00243	0.00666	CcSEcCtD
Nimodipine—Nausea—Hydroxyurea—head and neck cancer	0.00236	0.00646	CcSEcCtD
Nimodipine—Anaemia—Docetaxel—head and neck cancer	0.00233	0.0064	CcSEcCtD
Nimodipine—Palpitations—Docetaxel—head and neck cancer	0.00223	0.00612	CcSEcCtD
Nimodipine—Hypertension—Docetaxel—head and neck cancer	0.00218	0.00598	CcSEcCtD
Nimodipine—Myalgia—Docetaxel—head and neck cancer	0.00215	0.00589	CcSEcCtD
Nimodipine—Hypersensitivity—Fluorouracil—head and neck cancer	0.0021	0.00577	CcSEcCtD
Nimodipine—Oedema—Docetaxel—head and neck cancer	0.00206	0.00565	CcSEcCtD
Nimodipine—Nervous system disorder—Docetaxel—head and neck cancer	0.00202	0.00554	CcSEcCtD
Nimodipine—Pruritus—Fluorouracil—head and neck cancer	0.00202	0.00554	CcSEcCtD
Nimodipine—Thrombocytopenia—Docetaxel—head and neck cancer	0.00202	0.00553	CcSEcCtD
Nimodipine—Tachycardia—Docetaxel—head and neck cancer	0.00201	0.00552	CcSEcCtD
Nimodipine—Diarrhoea—Fluorouracil—head and neck cancer	0.00195	0.00536	CcSEcCtD
Nimodipine—Hypotension—Docetaxel—head and neck cancer	0.00193	0.00528	CcSEcCtD
Nimodipine—Dizziness—Fluorouracil—head and neck cancer	0.00189	0.00518	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00188	0.00515	CcSEcCtD
Nimodipine—Dyspnoea—Docetaxel—head and neck cancer	0.00184	0.00504	CcSEcCtD
Nimodipine—Vomiting—Fluorouracil—head and neck cancer	0.00182	0.00498	CcSEcCtD
Nimodipine—Rash—Fluorouracil—head and neck cancer	0.0018	0.00494	CcSEcCtD
Nimodipine—Dermatitis—Fluorouracil—head and neck cancer	0.0018	0.00493	CcSEcCtD
Nimodipine—NR3C2—Generic Transcription Pathway—RARB—head and neck cancer	0.0018	0.0063	CbGpPWpGaD
Nimodipine—Headache—Fluorouracil—head and neck cancer	0.00179	0.0049	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00178	0.00488	CcSEcCtD
Nimodipine—CACNA1D—Alzheimers Disease—CASP8—head and neck cancer	0.00177	0.00618	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—CEBPA—head and neck cancer	0.00173	0.00605	CbGpPWpGaD
Nimodipine—Nausea—Fluorouracil—head and neck cancer	0.0017	0.00465	CcSEcCtD
Nimodipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00168	0.00588	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.00165	0.00577	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—YAP1—head and neck cancer	0.00164	0.00573	CbGpPWpGaD
Nimodipine—AHR—Adipogenesis—STAT3—head and neck cancer	0.0016	0.00561	CbGpPWpGaD
Nimodipine—CACNB3—NCAM signaling for neurite out-growth—HRAS—head and neck cancer	0.0016	0.00559	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.00159	0.00557	CbGpPWpGaD
Nimodipine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00157	0.0055	CbGpPWpGaD
Nimodipine—CACNB1—NCAM signaling for neurite out-growth—HRAS—head and neck cancer	0.00155	0.00544	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—CASP8—head and neck cancer	0.00155	0.00543	CbGpPWpGaD
Nimodipine—Hypersensitivity—Docetaxel—head and neck cancer	0.00152	0.00416	CcSEcCtD
Nimodipine—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.00151	0.00528	CbGpPWpGaD
Nimodipine—CACNA1S—NCAM signaling for neurite out-growth—MAPK3—head and neck cancer	0.00149	0.00522	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—CEBPA—head and neck cancer	0.00148	0.00519	CbGpPWpGaD
Nimodipine—Pruritus—Docetaxel—head and neck cancer	0.00146	0.004	CcSEcCtD
Nimodipine—AHR—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.00144	0.00503	CbGpPWpGaD
Nimodipine—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.00143	0.005	CbGpPWpGaD
Nimodipine—CACNA1S—NCAM signaling for neurite out-growth—MAPK1—head and neck cancer	0.00142	0.00496	CbGpPWpGaD
Nimodipine—Diarrhoea—Docetaxel—head and neck cancer	0.00141	0.00387	CcSEcCtD
Nimodipine—CACNA1D—Developmental Biology—CEBPA—head and neck cancer	0.0014	0.00491	CbGpPWpGaD
Nimodipine—Dizziness—Docetaxel—head and neck cancer	0.00136	0.00374	CcSEcCtD
Nimodipine—CACNA1S—Alzheimers Disease—MAPK3—head and neck cancer	0.00132	0.00463	CbGpPWpGaD
Nimodipine—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.00131	0.0046	CbGpPWpGaD
Nimodipine—Vomiting—Docetaxel—head and neck cancer	0.00131	0.00359	CcSEcCtD
Nimodipine—Rash—Docetaxel—head and neck cancer	0.0013	0.00356	CcSEcCtD
Nimodipine—Dermatitis—Docetaxel—head and neck cancer	0.0013	0.00356	CcSEcCtD
Nimodipine—AHR—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.00129	0.00453	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.00129	0.00453	CbGpPWpGaD
Nimodipine—Headache—Docetaxel—head and neck cancer	0.00129	0.00354	CcSEcCtD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—MAPK3—head and neck cancer	0.00128	0.00447	CbGpPWpGaD
Nimodipine—AHR—Circadian rythm related genes—PTEN—head and neck cancer	0.00127	0.00443	CbGpPWpGaD
Nimodipine—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00126	0.00442	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—MAPK1—head and neck cancer	0.00126	0.0044	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—CEBPA—head and neck cancer	0.00123	0.00432	CbGpPWpGaD
Nimodipine—Nausea—Docetaxel—head and neck cancer	0.00122	0.00336	CcSEcCtD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—MAPK1—head and neck cancer	0.00121	0.00425	CbGpPWpGaD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—MAPK3—head and neck cancer	0.00121	0.00423	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—UROD—head and neck cancer	0.00121	0.00422	CbGpPWpGaD
Nimodipine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00117	0.00411	CbGpPWpGaD
Nimodipine—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00116	0.00405	CbGpPWpGaD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—MAPK1—head and neck cancer	0.00115	0.00403	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—UROD—head and neck cancer	0.00114	0.004	CbGpPWpGaD
Nimodipine—CACNA1S—NCAM signaling for neurite out-growth—HRAS—head and neck cancer	0.00114	0.00398	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.00109	0.0038	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—NAT2—head and neck cancer	0.00108	0.00378	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—MAPK3—head and neck cancer	0.00107	0.00376	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—NAT2—head and neck cancer	0.00106	0.00373	CbGpPWpGaD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—MAPK3—head and neck cancer	0.00106	0.00372	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—TP53—head and neck cancer	0.00106	0.0037	CbGpPWpGaD
Nimodipine—CACNB4—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.00105	0.00368	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—MAPK1—head and neck cancer	0.00102	0.00357	CbGpPWpGaD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—MAPK1—head and neck cancer	0.00101	0.00354	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—UROD—head and neck cancer	0.001	0.00352	CbGpPWpGaD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—HRAS—head and neck cancer	0.000975	0.00342	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—NOTCH1—head and neck cancer	0.000967	0.00339	CbGpPWpGaD
Nimodipine—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000951	0.00333	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—MAPK3—head and neck cancer	0.000942	0.0033	CbGpPWpGaD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—HRAS—head and neck cancer	0.000924	0.00323	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000917	0.00321	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—MAPK1—head and neck cancer	0.000897	0.00314	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—RARB—head and neck cancer	0.000866	0.00303	CbGpPWpGaD
Nimodipine—AHR—Circadian rythm related genes—TP53—head and neck cancer	0.000863	0.00302	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—TP53—head and neck cancer	0.000857	0.003	CbGpPWpGaD
Nimodipine—CACNB4—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000843	0.00295	CbGpPWpGaD
Nimodipine—CACNB3—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000839	0.00294	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—NAT2—head and neck cancer	0.00082	0.00287	CbGpPWpGaD
Nimodipine—CACNB1—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000816	0.00286	CbGpPWpGaD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—HRAS—head and neck cancer	0.000812	0.00284	CbGpPWpGaD
Nimodipine—CACNB4—Neuronal System—MAPK1—head and neck cancer	0.000804	0.00282	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—VEGFA—head and neck cancer	0.000793	0.00278	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—YAP1—head and neck cancer	0.000788	0.00276	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—NOTCH1—head and neck cancer	0.000773	0.00271	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—TP53—head and neck cancer	0.000753	0.00264	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—NOTCH1—head and neck cancer	0.000752	0.00263	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—MAPK3—head and neck cancer	0.00075	0.00263	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000737	0.00258	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—DPYD—head and neck cancer	0.000719	0.00252	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—MAPK1—head and neck cancer	0.000714	0.0025	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—EGFR—head and neck cancer	0.000713	0.0025	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—YAP1—head and neck cancer	0.000682	0.00239	CbGpPWpGaD
Nimodipine—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000675	0.00236	CbGpPWpGaD
Nimodipine—CACNB3—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000674	0.00236	CbGpPWpGaD
Nimodipine—CACNB1—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000655	0.00229	CbGpPWpGaD
Nimodipine—CACNB4—Neuronal System—HRAS—head and neck cancer	0.000646	0.00226	CbGpPWpGaD
Nimodipine—CACNB3—Neuronal System—MAPK1—head and neck cancer	0.000643	0.00225	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—VEGFA—head and neck cancer	0.000634	0.00222	CbGpPWpGaD
Nimodipine—CACNB1—Neuronal System—MAPK1—head and neck cancer	0.000625	0.00219	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—VEGFA—head and neck cancer	0.000616	0.00216	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—MAPK3—head and neck cancer	0.000599	0.0021	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—MAPK3—head and neck cancer	0.000583	0.00204	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—HRAS—head and neck cancer	0.000573	0.00201	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—MAPK1—head and neck cancer	0.00057	0.002	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—EGFR—head and neck cancer	0.00057	0.002	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—VEGFA—head and neck cancer	0.000566	0.00198	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—STAT3—head and neck cancer	0.00056	0.00196	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—MAPK1—head and neck cancer	0.000555	0.00194	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—EGFR—head and neck cancer	0.000555	0.00194	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—NOTCH1—head and neck cancer	0.000551	0.00193	CbGpPWpGaD
Nimodipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000545	0.00191	CbGpPWpGaD
Nimodipine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000538	0.00188	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—MAPK3—head and neck cancer	0.000535	0.00187	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	0.000533	0.00187	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	0.000526	0.00184	CbGpPWpGaD
Nimodipine—CACNB3—Neuronal System—HRAS—head and neck cancer	0.000516	0.00181	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000513	0.00179	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—MAPK1—head and neck cancer	0.000509	0.00178	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—EGFR—head and neck cancer	0.000509	0.00178	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	0.000505	0.00177	CbGpPWpGaD
Nimodipine—CACNB1—Neuronal System—HRAS—head and neck cancer	0.000502	0.00176	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000502	0.00176	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—NAT2—head and neck cancer	0.000501	0.00175	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000498	0.00174	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000495	0.00173	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—NAT2—head and neck cancer	0.000474	0.00166	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—NOTCH1—head and neck cancer	0.000472	0.00165	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—HRAS—head and neck cancer	0.000458	0.0016	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—VEGFA—head and neck cancer	0.000452	0.00158	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—VEGFA—head and neck cancer	0.000452	0.00158	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—STAT3—head and neck cancer	0.000448	0.00157	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—NOTCH1—head and neck cancer	0.000447	0.00157	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—HRAS—head and neck cancer	0.000445	0.00156	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—UROD—head and neck cancer	0.000444	0.00156	CbGpPWpGaD
Nimodipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000442	0.00155	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—VEGFA—head and neck cancer	0.00044	0.00154	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—DPYD—head and neck cancer	0.000439	0.00154	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—STAT3—head and neck cancer	0.000436	0.00153	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—MAPK3—head and neck cancer	0.000428	0.0015	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—MAPK3—head and neck cancer	0.000427	0.0015	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—NAT2—head and neck cancer	0.000417	0.00146	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—YAP1—head and neck cancer	0.000417	0.00146	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—MAPK3—head and neck cancer	0.000416	0.00146	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—DPYD—head and neck cancer	0.000416	0.00146	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000412	0.00144	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—TYMS—head and neck cancer	0.00041	0.00143	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—HRAS—head and neck cancer	0.000409	0.00143	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—MAPK1—head and neck cancer	0.000407	0.00143	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—EGFR—head and neck cancer	0.000407	0.00143	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—MAPK1—head and neck cancer	0.000406	0.00142	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—EGFR—head and neck cancer	0.000406	0.00142	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GSTM1—head and neck cancer	0.000405	0.00142	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—MAPK1—head and neck cancer	0.000396	0.00139	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—EGFR—head and neck cancer	0.000396	0.00139	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—YAP1—head and neck cancer	0.000395	0.00138	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—NOTCH1—head and neck cancer	0.000393	0.00138	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—MAPK1—head and neck cancer	0.000393	0.00138	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GPX1—head and neck cancer	0.000388	0.00136	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—VEGFA—head and neck cancer	0.000387	0.00136	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CYP1A1—head and neck cancer	0.000384	0.00134	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—VEGFA—head and neck cancer	0.000367	0.00128	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—MAPK3—head and neck cancer	0.000366	0.00128	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—DPYD—head and neck cancer	0.000366	0.00128	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—AKT1—head and neck cancer	0.000361	0.00126	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—NOTCH1—head and neck cancer	0.000355	0.00124	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—MAPK1—head and neck cancer	0.000348	0.00122	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—EGFR—head and neck cancer	0.000348	0.00122	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—YAP1—head and neck cancer	0.000347	0.00121	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—MAPK3—head and neck cancer	0.000347	0.00121	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—MAPK1—head and neck cancer	0.00033	0.00116	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—EGFR—head and neck cancer	0.00033	0.00116	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—HRAS—head and neck cancer	0.000327	0.00114	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—HRAS—head and neck cancer	0.000326	0.00114	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—VEGFA—head and neck cancer	0.000322	0.00113	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—VEGFA—head and neck cancer	0.000322	0.00113	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—STAT3—head and neck cancer	0.000319	0.00112	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—HRAS—head and neck cancer	0.000318	0.00111	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—HRAS—head and neck cancer	0.000315	0.0011	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MAPK3—head and neck cancer	0.000305	0.00107	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MAPK3—head and neck cancer	0.000305	0.00107	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MAPK1—head and neck cancer	0.00029	0.00102	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—EGFR—head and neck cancer	0.00029	0.00102	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MAPK1—head and neck cancer	0.00029	0.00102	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—EGFR—head and neck cancer	0.00029	0.00102	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—AKT1—head and neck cancer	0.000289	0.00101	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—AKT1—head and neck cancer	0.000281	0.000983	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—HRAS—head and neck cancer	0.00028	0.00098	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—VEGFA—head and neck cancer	0.000276	0.000967	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—STAT3—head and neck cancer	0.000274	0.000958	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—HRAS—head and neck cancer	0.000265	0.000928	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—VEGFA—head and neck cancer	0.000262	0.000916	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MAPK3—head and neck cancer	0.000261	0.000915	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—STAT3—head and neck cancer	0.000259	0.000907	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—TYMS—head and neck cancer	0.00025	0.000877	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MAPK1—head and neck cancer	0.000249	0.000871	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—EGFR—head and neck cancer	0.000249	0.000871	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000248	0.000868	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MAPK3—head and neck cancer	0.000247	0.000867	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSTM1—head and neck cancer	0.000247	0.000866	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000244	0.000856	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—TYMS—head and neck cancer	0.000237	0.00083	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GPX1—head and neck cancer	0.000237	0.00083	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MAPK1—head and neck cancer	0.000235	0.000825	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—EGFR—head and neck cancer	0.000235	0.000824	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000235	0.000822	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP1A1—head and neck cancer	0.000235	0.000821	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTM1—head and neck cancer	0.000234	0.000821	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—HRAS—head and neck cancer	0.000233	0.000815	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—HRAS—head and neck cancer	0.000233	0.000815	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000232	0.000811	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—VEGFA—head and neck cancer	0.00023	0.000805	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTGS2—head and neck cancer	0.000228	0.0008	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—STAT3—head and neck cancer	0.000228	0.000797	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GPX1—head and neck cancer	0.000224	0.000786	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP1A1—head and neck cancer	0.000222	0.000778	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MAPK3—head and neck cancer	0.000217	0.000761	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—TYMS—head and neck cancer	0.000208	0.000729	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MAPK1—head and neck cancer	0.000207	0.000725	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—EGFR—head and neck cancer	0.000207	0.000724	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—UROD—head and neck cancer	0.000207	0.000723	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTM1—head and neck cancer	0.000206	0.000721	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—AKT1—head and neck cancer	0.000206	0.00072	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—HRAS—head and neck cancer	0.0002	0.000699	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTEN—head and neck cancer	0.000199	0.000697	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GPX1—head and neck cancer	0.000197	0.00069	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MAPK3—head and neck cancer	0.000196	0.000688	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP1A1—head and neck cancer	0.000195	0.000683	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—HRAS—head and neck cancer	0.000189	0.000662	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NAT2—head and neck cancer	0.000185	0.000646	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—AKT1—head and neck cancer	0.000176	0.000617	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—AKT1—head and neck cancer	0.000167	0.000585	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—HRAS—head and neck cancer	0.000166	0.000582	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—DPYD—head and neck cancer	0.000162	0.000567	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—YAP1—head and neck cancer	0.000154	0.000538	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—AKT1—head and neck cancer	0.000147	0.000514	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CA—head and neck cancer	0.00014	0.000492	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTGS2—head and neck cancer	0.000139	0.000488	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—AKT1—head and neck cancer	0.000132	0.000464	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTGS2—head and neck cancer	0.000132	0.000463	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTEN—head and neck cancer	0.000122	0.000426	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTGS2—head and neck cancer	0.000116	0.000406	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTEN—head and neck cancer	0.000115	0.000403	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—AKT1—head and neck cancer	0.000115	0.000402	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTEN—head and neck cancer	0.000101	0.000354	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TYMS—head and neck cancer	9.22e-05	0.000323	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTM1—head and neck cancer	9.11e-05	0.000319	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GPX1—head and neck cancer	8.73e-05	0.000306	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP1A1—head and neck cancer	8.64e-05	0.000303	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CA—head and neck cancer	8.58e-05	0.000301	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NAT2—head and neck cancer	8.58e-05	0.0003	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CA—head and neck cancer	8.13e-05	0.000285	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—DPYD—head and neck cancer	7.52e-05	0.000263	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CA—head and neck cancer	7.14e-05	0.00025	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—YAP1—head and neck cancer	7.14e-05	0.00025	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—AKT1—head and neck cancer	7.01e-05	0.000246	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—AKT1—head and neck cancer	6.64e-05	0.000232	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—AKT1—head and neck cancer	5.83e-05	0.000204	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTGS2—head and neck cancer	5.14e-05	0.00018	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTEN—head and neck cancer	4.48e-05	0.000157	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TYMS—head and neck cancer	4.29e-05	0.00015	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTM1—head and neck cancer	4.24e-05	0.000148	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GPX1—head and neck cancer	4.06e-05	0.000142	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	4.02e-05	0.000141	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CA—head and neck cancer	3.16e-05	0.000111	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AKT1—head and neck cancer	2.58e-05	9.04e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTGS2—head and neck cancer	2.39e-05	8.36e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTEN—head and neck cancer	2.08e-05	7.29e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.47e-05	5.15e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AKT1—head and neck cancer	1.2e-05	4.2e-05	CbGpPWpGaD
